ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it will present at the Rodman & Renshaw 12th Annual Healthcare Conference on September 14, 2010, at 11:15 a.m. Eastern Time at the New York Palace Hotel in New York, NY.
